ExoPTEN therapy

N/A

Report date: 2024/07/10 11:08:19
NME

Base Information

Drug NameExoPTEN therapy
Drug Alias NamePhosphatase and tensin homolog siRNA loaded exosome therapy (NurExone Biologic)Biologically-guided exosome therapy (NurExone Biologic)ExoPTEN therapyPTEN inhibition-based exosome therapy (NurExone Biologic)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives
Mechanisms of ActionPhosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN inhibitorsRNA interference
TargetsPhosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN
Therapy Area/IndicationsGlaucomaSpinal Cord Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIsrael
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNurExone Biologic Inc
China Registration ClassN/A

Develop Information

Active CompaniesNurExone Biologic IncTel Aviv University
Inactive CompaniesN/A
Active IndicationsGlaucomaSpinal Cord Injuries
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A